Toronto Dominion Bank
TEVA icon

Toronto Dominion Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Toronto Dominion Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,723
Closed -$373K – 1584
2024
Q3 		$373K Buy
20,723
+19
+0.1% +$333 ﹤0.01% 908
2024
Q2 		$336K Buy
20,704
+20,585
+17,298% +$317K ﹤0.01% 979
2024
Q1 		$1.68K Buy
119
+23
+24% +$290 ﹤0.01% 1199
2023
Q4 		$1K Sell
96
-3,004
-97% -$28K ﹤0.01% 1327
2023
Q3 		$31.6K Sell
3,100
-247
-7% -$2.3K ﹤0.01% 1238
2023
Q2 		$26K Sell
3,347
-607
-15% -$4.92K ﹤0.01% 1250
2023
Q1 		$35K Buy
3,954
+559
+16% +$5.53K ﹤0.01% 1239
2022
Q4 		$31K Buy
+3,395
New +$29.6K ﹤0.01% 1345
2022
Q3 		– Sell
-1
Closed – – 1706
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1854
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1961
2021
Q4 		$0 Hold
1
– – ﹤0.01% 1987
2021
Q3 		$0 Sell
1
-799
-100% -$7.48K ﹤0.01% 1475
2021
Q2 		$8K Hold
800
– – ﹤0.01% 1263
2021
Q1 		$9K Hold
800
– – ﹤0.01% 1300
2020
Q4 		$8K Hold
800
– – ﹤0.01% 1234
2020
Q3 		$7K Buy
+800
New +$8.46K ﹤0.01% 1109
2020
Q2 		– Sell
-60
Closed -$1K – 1367
2020
Q1 		$1K Sell
60
-18,970
-100% -$194K ﹤0.01% 1209
2019
Q4 		$186K Buy
+19,030
New +$170K ﹤0.01% 1019
2019
Q1 		– Sell
-27,300
Closed -$421K – 1723
2018
Q4 		$421K Sell
27,300
-200
-0.7% -$4.1K ﹤0.01% 1028
2018
Q3 		$592K Hold
27,500
– – ﹤0.01% 975
2018
Q2 		$669K Buy
+27,500
New +$561K ﹤0.01% 992
2017
Q4 		– Sell
-1,440
Closed -$25K – 1298
2017
Q3 		$25K Sell
1,440
-1,460
-50% -$32.9K ﹤0.01% 1052
2017
Q2 		$96K Sell
2,900
-900
-24% -$27.9K ﹤0.01% 962
2017
Q1 		$122K Sell
3,800
-387
-9% -$13.2K ﹤0.01% 907
2016
Q4 		$152K Sell
4,187
-1,455
-26% -$58.1K ﹤0.01% 850
2016
Q3 		$260K Sell
5,642
-383
-6% -$20K ﹤0.01% 764
2016
Q2 		$304K Buy
6,025
+35
+0.6% +$1.86K ﹤0.01% 512
2016
Q1 		$319K Sell
5,990
-573
-9% -$33.6K ﹤0.01% 463
2015
Q4 		$432K Sell
6,563
-369
-5% -$22.8K ﹤0.01% 570
2015
Q3 		$393K Buy
6,932
+2,331
+51% +$151K ﹤0.01% 572
2015
Q2 		$272K Hold
4,601
– – ﹤0.01% 710
2015
Q1 		$287K Sell
4,601
-269
-6% -$15.6K ﹤0.01% 685
2014
Q4 		$280K Buy
+4,870
New +$271K ﹤0.01% 736
2014
Q3 		– Sell
-1,475
Closed -$77K – 1020
2014
Q2 		$77K Sell
1,475
-970
-40% -$49.6K ﹤0.01% 898
2014
Q1 		$134K Sell
2,445
-975
-29% -$45.1K ﹤0.01% 794
2013
Q4 		$137K Sell
3,420
-130
-4% -$5.12K ﹤0.01% 756
2013
Q3 		$134K Buy
3,550
+130
+4% +$5.07K ﹤0.01% 534
2013
Q2 		$134K Buy
+3,420
New +$133K ﹤0.01% 546

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Toronto Dominion Bank's TEVA Position: Q4 2024 in Review

Toronto Dominion Bank sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 20,723 shares — an estimated $373K sold.

Toronto Dominion Bank first reported a position in TEVA in Q2 2013 and held it in 38 quarters. The position peaked at $669K in Q2 2018. 583 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Toronto Dominion Bank reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 20,723 Teva Pharmaceuticals shares in Q4 2024, an estimated $373K.
  • Toronto Dominion Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 38 quarters.
  • Toronto Dominion Bank's Teva Pharmaceuticals position peaked at $669K in Q2 2018.
  • 583 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Toronto Dominion Bank's 13F filing for Q4 2024, filed 14 Feb 2025.